BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 15456463)

  • 1. Review article: towards consistency in the endoscopic diagnosis of Barrett's oesophagus and columnar metaplasia.
    Armstrong D
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():40-7; discussion 61-2. PubMed ID: 15456463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
    Sharma P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When and how to grade Barrett's columnar metaplasia: the Prague system.
    Anand O; Wani S; Sharma P
    Best Pract Res Clin Gastroenterol; 2008; 22(4):661-9. PubMed ID: 18656823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
    Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
    Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's oesophagus: the new endoscopic modalities have a future.
    Deviere J
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines.
    van Sandick JW; Bartelsman JF; van Lanschot JJ; Tytgat GN; Obertop H
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):111-7. PubMed ID: 10656220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies of the cardiac mucosa and Barrett's oesophagus.
    Chandrasoma P
    Histopathology; 2005 Apr; 46(4):361-73. PubMed ID: 15810947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].
    Peitz U; Malfertheiner P
    Z Gastroenterol; 2007 Dec; 45(12):1264-72. PubMed ID: 18080229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A surveillance programme for Barrett's oesophagus in a UK general hospital.
    Olithselvan A; Gorard DA; McIntyre AS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
    Morris CD; Byrne JP; Armstrong GR; Attwood SE
    Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus.
    Fortun PJ; Anagnostopoulos GK; Kaye P; James M; Foley S; Samuel S; Shonde A; Badreldin R; Campbell E; Hawkey CJ; Ragunath K
    Aliment Pharmacol Ther; 2006 Mar; 23(6):735-42. PubMed ID: 16556175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: emerging techniques for screening and surveillance in Barrett's oesophagus.
    Sharma P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():63-70; discussion 95-6. PubMed ID: 15456467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's oesophagus: diagnosis and management.
    Spechler SJ
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Oct; 14(5):857-79. PubMed ID: 11003814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.